NYSE · Healthcare · Medical Instruments & Supplies · USA
Baxter International Inc is a large cap company (market value between $10 billion and $200 billion) in the Medical Instruments & Supplies industry.
Baxter International provides essential healthcare products including sterile IV solutions, infusion systems, parenteral nutrition therapies, inhaled anesthetics, injectable pharmaceuticals, surgical products, smart beds, patient monitoring technologies, and respiratory devices. These products serve hospitals, nursing homes, surgery centers, dialysis facilities, doctors' offices, and patients at home across multiple countries.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the Baxter International Inc stock.
Overvalued: intrinsic value $4.20 per share, market price $24.99, margin of safety -494.9% (as of 2026-10-19).
Its through-the-cycle earnings (7.1% median margin), capitalised at 7.7% with no growth, values the shares at $4.20; the price of $24.99 is 495% above that value.
Leak Score: 39/100 on 10 of 12 signals (On Watch).
17 more funds hold it; the full list is part of the paid plan.
All 50 Medical Instruments & Supplies stocks
19 more in this industry show a wider margin of safety.
BAX is overvalued (as of the 2026-10-19 close). Its through-the-cycle earnings (7.1% median margin), capitalised at 7.7% with no growth, values the shares at $4.20; the price of $24.99 is 495% above that value.
$4.20 per share (as of the 2026-10-19 close), against a market price of $24.99. That is a margin of safety of -494.9%. The value is the average of the valuation methods that apply to this company, recomputed every night after the US close.
39 out of 100, which we rate "On Watch", on 10 of 12 value investing signals.